• Filing Date: 2021-03-31
  • Form Type: 10-K
  • Description: Annual report
v3.21.1
Supplemental Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Supplemental Cash Flow Information [Abstract]    
Cash paid for interest $ 185,000 $ 128,000
Impact of adoption of lease accounting standards 1,616,000
Gain from change in fair value of interest rate swap derivatives 7,000
Common stock issued upon conversion of convertible note 500,000
Equity issued to purchase intangible assets 145,000
Common A Shares issued for prepaid marketing services 210,000
Common A Shares issued for Impact BioMedical 3,132,000
Non-controlling interest related to Impact BioMedical 3,910,000  
Series A Preferred Shares issued for Impact BioMedical 35,187,000
RBC & HWH notes receivable for assets in lieu of cash $ 838,000